FDA draws fine line between health and wellness apps; Colorado gives biosimilar swap law another look; ZMapp is set to start human trials of its Ebola vaccine.
Phunware's VP Product Evangelist will explore how hospitals can implement a wayfinding and messaging solution, and how they can expect to benefit from it.
The snag: identifying what qualifies as download-worthy.
United Healthcare's Baby Blocks app seeks to become all-in-one hub for expectant moms and their babies.
Ackman walks away with $2.5 billion, despite no Allergan deal; Ranbaxy sues FDA over generic Nexium rights; Indian government's Health Ministry recommends breaking BMS cancer drug patent.
A trio of doctors make a case for putting limits on digital promotions, including those in EHRs and through social networks.
Researchers say the iPad app could help assess vision loss.
The Post X-er, Post-Boomer generation considers traditional healthcare "sick care."
Mobile health devices may be more than they appear to be—consumers are taking an open-source approach to getting the monitors they want.
Lightbulb company Royal Philips is swapping its heritage for the consumer healthcare business.
Healthcare workers seek out health-related information on their own time, and through internet connections other than ones offered by their employers.
Novartis explores the virtual care space, a court has dismissed a lawsuit against IPAB, Doctors Without Borders calls the Ebola outbreak "a complete disaster" and Pfizer becomes the first pharma company to pair with the Crohn's and Colitis Foundation of America.
A study indicates consumers stop using them at the six-month mark.
Patients want to do more with mobile and see doctors less. Two studies outline the types of digital interventions patients are interested in.
Recent FDA guidelines for health-tracking apps mean Apple's HealthKit, and similar apps, won't have to jump regulatory hurdles before going live.
The health and lifestyle resource's latest app seeks to provide context for all that biometric data consumers are storing in wearables, wireless scales and glucometers.
The bedside decision-making app includes clinical trial and drug information as well as breaking news.
Texting HCPs may be speedy, but a study finds some built-in risks.
A study by consulting firm Accenture shows that patients not only expect digital outreach, but that their desire to be engaged is consistently being ignored.
@openFDA and its related website launched February 27.
GoQii seeks to convert tracked calories, steps and distance into a philanthropic device.
Survey questions can be uploaded as needed.
Movable Ink reports that 65% of Q4 emails were opened on a tablet or smartphone.
A six-month pilot program at the University of Chicago improved glycemic control and engaged patients and HCPs through one key device: a mobile phone.
TapTrak seeks to apply behavioral tracking to clinical trials.
Chronic disease patients seek online support and information, and show little love for branded websites.
Summaries max out at 160 characters and most queries are clinical.
The voice-activated app costs 99 cents.
The company says it recaptured some former advertisers and that third-quarter traffic is up compared with last year.
Smartphone users, while in the exam room, are more apt to be in "switch mentality," a study finds.
Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.
- Novartis psoriasis drug approval could upend market
- Sandoz gets ready to make the biosimilar case with oncologists
- Guidemark Health jumpstarts rebrand, brings on big-agency grad
- MM&M's 5 minutes with: Mark Rothera, chief commercial officer, PTC Therapeutics
- Nurse practitioner workforce has just about doubled